BoI Official Confident of Biotechnology Future (Thailand)
This article was originally published in PharmAsia News
Executive Summary
Ajarin Pattanapanchai, executive investment adviser for Thailand's Board of Investment, says the emergence of a number of multinational and local companies in the biotechnology business underlines the success of efforts to grow its biotechnology industry. Though Thailand is behind Japan, Singapore, Korea, Malaysia, China, and India in promoting biotechnology, Pattanapanchai points out that the industry depends on personnel with exceptional skills, providing Thailand with an opportunity to catch up by focusing on that area. ''We continue developing and producing personnel from both the state and private educational institutions, especially through strong support from the National Science and Technology Development Agency,'' she says. The entry of multinationals to set up blood banks for special disease diagnosis, stem cell processing, drug production, environmental conservation, and increased productivity for agro-processing industries are all positive signs for the emerging biotech industry. (Click here for more
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.